Invention Grant
- Patent Title: Auto-active and intracellular mutant of MET
-
Application No.: US15528322Application Date: 2015-11-18
-
Publication No.: US11035860B2Publication Date: 2021-06-15
- Inventor: Anna Catharina Navis , Wilhelmus Petrus Johannes Leenders , Thomas Würdinger
- Applicant: Stichting Katholieke Universiteit , Stichting VU-Vumc
- Applicant Address: NL Nijmegen; NL Amsterdam
- Assignee: Stichting Katholieke Universiteit,Stichting VU-Vumc
- Current Assignee: Stichting Katholieke Universiteit,Stichting VU-Vumc
- Current Assignee Address: NL Nijmegen; NL Amsterdam
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP14194066 20141120
- International Application: PCT/EP2015/076989 WO 20151118
- International Announcement: WO2016/079194 WO 20160526
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/574 ; C12Q1/6886 ; C07K14/71 ; C12Q1/6883 ; G01N33/74 ; A61K39/00 ; C07K16/28
Abstract:
The present invention relates to the fields of medicine and molecular diagnostics. In particular, it relates to a novel method for the treatment, prevention and/or delay of cancer and to a diagnostic method involving detection of a novel auto-active and intracellular mutant of MET.
Public/Granted literature
- US20170322215A1 A Novel Auto-Active and Intracellular Mutant of MET Public/Granted day:2017-11-09
Information query
